{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:28:00Z","timestamp":1787012880676,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55419-7","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:24:22Z","timestamp":1780755862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Creatinine-normalized urinary lipocalin-2 in children with obesity: association with insulin resistance in a cross-sectional study"],"prefix":"10.1038","volume":"16","author":[{"given":"Aydin","family":"Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busra Karadag","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"55419_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 403, 1027\u20131050 (2024).","journal-title":"Lancet"},{"key":"55419_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s13679-021-00439-9","volume":"10","author":"A Horesh","year":"2021","unstructured":"Horesh, A., Tsur, A. M., Bardugo, A. & Twig, G. Adolescent and childhood obesity and excess morbidity and mortality in young adulthood: a systematic review. Curr. Obes. Rep. 10, 301\u2013310 (2021).","journal-title":"Curr. Obes. Rep."},{"key":"55419_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4103\/1735-1995.156179","volume":"20","author":"R Kelishadi","year":"2015","unstructured":"Kelishadi, R., Mirmoghtadaee, P., Najafi, H. & Keikha, M. Systematic review on the association of abdominal obesity in children and adolescents with cardiometabolic risk factors. J. Res. Med. Sci. 20, 294\u2013307 (2015).","journal-title":"J. Res. Med. Sci."},{"key":"55419_CR4","doi-asserted-by":"publisher","first-page":"A18","DOI":"10.1016\/j.clinthera.2012.12.014","volume":"35","author":"ER Pulgar\u00f3n","year":"2013","unstructured":"Pulgar\u00f3n, E. R. Childhood obesity: increased risk for physical and psychological comorbidities. Clin. Ther. 35, A18\u201332 (2013).","journal-title":"Clin. Ther."},{"issue":"11\u201312","key":"55419_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","volume":"14","author":"K Rabe","year":"2008","unstructured":"Rabe, K., Lehrke, M., Parhofer, K. G. & Broedl, U. C. Adipokines and insulin resistance. Mol. Med. 14 (11\u201312), 741\u2013751 (2008).","journal-title":"Mol. Med."},{"issue":"1","key":"55419_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1373\/clinchem.2006.075614","volume":"53","author":"Y Wang","year":"2007","unstructured":"Wang, Y. et al. Lipocalin-2 is an inflammatory marker closely associated with obesity and insulin resistance in humans. Clin. Chem. 53 (1), 34\u201341 (2007).","journal-title":"Clin. Chem."},{"key":"55419_CR7","doi-asserted-by":"crossref","first-page":"8163","DOI":"10.3390\/ijms21218163","volume":"21","author":"E De la Chesnaye","year":"2020","unstructured":"De la Chesnaye, E. et al. Lipocalin-2 in metabolic diseases and type 2 diabetes. Int. J. Mol. Sci. 21, 8163 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"55419_CR8","first-page":"905146","volume":"13","author":"A Asimakopoulou","year":"2022","unstructured":"Asimakopoulou, A. & Weiskirchen, R. Lipocalin 2 (LCN2) in obesity and metabolic disorders. Front. Endocrinol. (Lausanne). 13, 905146 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"55419_CR9","first-page":"575","volume":"32","author":"I Mosialou","year":"2021","unstructured":"Mosialou, I. et al. Emerging roles of lipocalin-2 in metabolic regulation and obesity. Trends Endocrinol. Metab. 32 (8), 575\u2013587 (2021).","journal-title":"Trends Endocrinol. Metab."},{"key":"55419_CR10","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2337\/db09-1735","volume":"59","author":"H Guo","year":"2010","unstructured":"Guo, H. et al. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 59, 1376\u20131385 (2010).","journal-title":"Diabetes"},{"issue":"2","key":"55419_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/ijo.2009.242","volume":"34","author":"JM Moreno-Navarrete","year":"2010","unstructured":"Moreno-Navarrete, J. M. et al. Metabolic endotoxemia contributes to circulating NGAL concentrations in subjects with insulin resistance. Int. J. Obes. (Lond). 34 (2), 240\u2013249 (2010).","journal-title":"Int. J. Obes. (Lond)"},{"issue":"10","key":"55419_CR12","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.2337\/db07-0007","volume":"56","author":"QW Yan","year":"2007","unstructured":"Yan, Q. W. et al. The adipokine lipocalin-2 is regulated by obesity and promotes insulin resistance. Diabetes 56 (10), 2533\u20132540 (2007).","journal-title":"Diabetes"},{"issue":"3","key":"55419_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ki.2008.499","volume":"75","author":"T Kuwabara","year":"2009","unstructured":"Kuwabara, T. et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect renal damage. Kidney Int. 75 (3), 285\u2013294 (2009).","journal-title":"Kidney Int."},{"issue":"7","key":"55419_CR14","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1373\/clinchem.2007.099002","volume":"54","author":"C Kanaka-Gantenbein","year":"2008","unstructured":"Kanaka-Gantenbein, C. et al. Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just small adults. Clin. Chem. 54 (7), 1176\u20131182 (2008).","journal-title":"Clin. Chem."},{"issue":"2","key":"55419_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1651-2227.2006.tb02206.x","volume":"95","author":"R Bundak","year":"2006","unstructured":"Bundak, R. et al. Body mass index references for Turkish children. Acta Paediatr. 95 (2), 194\u2013198 (2006).","journal-title":"Acta Paediatr."},{"issue":"4","key":"55419_CR16","doi-asserted-by":"publisher","first-page":"e500","DOI":"10.1542\/peds.2004-1921","volume":"115","author":"M Keskin","year":"2005","unstructured":"Keskin, M., Kurtoglu, S., Kendirci, M., Atabek, M. E. & Yazici, C. Homeostasis model assessment is more reliable than fasting glucose\/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115 (4), e500\u2013e503 (2005).","journal-title":"Pediatrics"},{"key":"55419_CR17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860\u2013867 (2006).","journal-title":"Nature"},{"key":"55419_CR18","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI57132","volume":"121","author":"CN Lumeng","year":"2011","unstructured":"Lumeng, C. N. & Saltiel, A. R. Inflammatory links between obesity and metabolic disease. J. Clin. Investig. 121, 2111\u20132117 (2011).","journal-title":"J. Clin. Investig."},{"key":"55419_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature21697","volume":"543","author":"I Mosialou","year":"2017","unstructured":"Mosialou, I. et al. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature 543, 385\u2013390 (2017).","journal-title":"Nature"},{"key":"55419_CR20","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2337\/db09-1541","volume":"59","author":"IK Law","year":"2010","unstructured":"Law, I. K. et al. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 59, 872\u2013882 (2010).","journal-title":"Diabetes"},{"issue":"3","key":"55419_CR21","first-page":"346","volume":"70","author":"V Catal\u00e1n","year":"2009","unstructured":"Catal\u00e1n, V. et al. Increased circulating lipocalin-2 levels in obesity are associated with inflammation and insulin resistance. Clin. Endocrinol. (Oxf). 70 (3), 346\u2013352 (2009).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"55419_CR22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cca.2008.04.002","volume":"394","author":"KM Choi","year":"2008","unstructured":"Choi, K. M. et al. Implication of lipocalin-2 and visfatin levels in patients with metabolic syndrome. Clin. Chim. Acta. 394, 54\u201358 (2008).","journal-title":"Clin. Chim. Acta"},{"key":"55419_CR23","first-page":"228","volume":"92","author":"T Reinehr","year":"2007","unstructured":"Reinehr, T., Stoffel-Wagner, B. & Roth, C. L. Adipocyte fatty acid-binding protein in obese children before and after weight loss. J. Clin. Endocrinol. Metab. 92, 228\u2013233 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"55419_CR24","first-page":"213","volume":"25","author":"D Panidis","year":"2010","unstructured":"Panidis, D. et al. Serum lipocalin-2 levels in obese women with polycystic ovary syndrome. Hum. Reprod. 25, 213\u2013220 (2010).","journal-title":"Hum. Reprod."},{"key":"55419_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1289\/ehp.7337","volume":"113","author":"DB Barr","year":"2005","unstructured":"Barr, D. B. et al. Urinary creatinine concentrations in the U.S. population: implications for biomonitoring measurements. Environ. Health Perspect. 113, 192\u2013200 (2005).","journal-title":"Environ. Health Perspect."},{"key":"55419_CR26","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1056\/NEJMoa031049","volume":"350","author":"R Weiss","year":"2004","unstructured":"Weiss, R. et al. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350, 2362\u20132374 (2004).","journal-title":"N. Engl. J. Med."},{"key":"55419_CR27","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1172\/JCI20514","volume":"112","author":"KE Wellen","year":"2003","unstructured":"Wellen, K. E. & Hotamisligil, G. S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Investig. 112, 1785\u20131788 (2003).","journal-title":"J. Clin. Investig."},{"key":"55419_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1172\/JCI23056","volume":"115","author":"K Mori","year":"2005","unstructured":"Mori, K. et al. Endocytic delivery of lipocalin-2 to tubular cells attenuates ischemic renal injury. J. Clin. Investig. 115, 610\u2013621 (2005).","journal-title":"J. Clin. Investig."},{"key":"55419_CR29","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z. & Hall, M. E. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ. Res. 116, 991\u20131006 (2015).","journal-title":"Circ. Res."},{"key":"55419_CR30","first-page":"397","volume":"30","author":"P Anagnostis","year":"2009","unstructured":"Anagnostis, P., Athyros, V. G., Tziomalos, K., Karagiannis, A. & Mikhailidis, D. P. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome. Endocr. Rev. 30, 397\u2013418 (2009).","journal-title":"Endocr. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55419-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55419-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55419-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:19:50Z","timestamp":1787012390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55419-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55419"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55419-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted at Kecioren Training and Research Hospital, Ankara, Turkiye. Ethical approval was obtained from the Kecioren Training and Research Hospital Ethics Committee (Approval No: B.10.4.\u0130SM.4.06.68.49-003; Date: January 12, 2012). All procedures were performed in accordance with the ethical standards of the institutional research committee and the principles of the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from the parents or legal guardians of all participants prior to enrollment in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25840"}}